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Abstract
The hypoxia-inducible factor-1α (HIF-1α) is an evolutionarily conserved transcription 
factor with prominent roles in the hypoxic response, cell survival, angiogenesis and can-
cer. HIF-1α functions as a sensor of molecular oxygen: in the presence of oxygen, it is 
degraded by the proteasome, whereas in reduced oxygen tensions, it heterodimerizes 
with the constitutively expressed HIF-1b subunit forming the functional HIF1 transcrip-
tion factor, which enters the nucleus to control expression of hypoxia-inducible genes. 
Since HIF-1α has been found upregulated in several cancers, it has attracted a lot of clini-
cal interest, because it represents an interesting candidate for pharmacological chemo-
therapy interventions. In this chapter, we discuss our current knowledge on the HIF1 
transcription factors and their major roles in development, physiology, angiogenesis and 
cancer using examples of recent studies in the model organism Drosophila melanogaster. 
Given the striking functional conservation between the mammalian and fruit fly HIF-1α, 
we expect that future studies in the Drosophila model will not only expand our knowledge 
on the basic HIF1 biology, but they will also pinpoint conserved molecular regulators of 
HIF1 that might lead to the discovery of novel cancer therapeutics.
Keywords: hypoxia, tumorigenesis, Warburg effect, metabolism, tracheogenesis, 
inflammation, Drosophila
1. HIF-1α in mammalian angiogenesis, inflammation and cancer
1.1. Oxygen is required for survival of all animals
Oxygen (O
2
) is the main ingredient of the atmospheric air and is required for the survival of 
all living organisms. It is also present in the seas and oceans, and it is necessary for survival 
of all aquatic living organisms. Oxygen accumulated on Earth’s atmosphere about 2.5 billion 
© 2018 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
years ago [1]. However, it was discovered only 245 years ago, by the chemist Carl Wilhelm 
Scheele [2]. Its main role in the survival of animals derives from its utilization during cellu-
lar respiration. Specifically, oxygen is involved in oxidative phosphorylation, the process that 
transfers the chemical energy stored in carbon bonds to the phosphate bonds of Adenosine 
Tri-Phosphate (ATP), which is the main energy carrier in all cell types of living organisms [3]. 
In addition, oxygen is the main component of ATP production, because it is the final electron 
acceptor of the respiratory chain. Oxygen-electron reaction leads to the release of reactive oxy-
gen species (ROS), which, when accumulated, results in oxidative stress and eventually cell 
death [4, 5]. Oxygen is necessary as an energy substrate, and the danger of oxidative dam-
age needs to be kept at equilibrium. Therefore, oxygen homeostasis is critical for all cellular 
processes, and its intermittent supply results in many pathophysiological conditions, such as 
myocardial ischemia, sepsis, pulmonary hypertension, chronic obstructive pulmonary disease 
and cancer, which correspond to frequent causes of mortality in the Western world [6].
The ambient oxygen concentration is 21%, and the cells of the majority of healthy tissues are 
exposed to less oxygen, which varies between 2 and 16% [6, 7]. Normoxia is defined as normal 
oxygen levels, whereas hypoxia is a situation where the organism is underprivileged of suf-
ficient oxygen supply. Hypoxia can be continuous or intermittent [4]. In anoxia, oxygen levels 
are strictly or totally insufficient, and in hyperoxia, oxygen is superfluous in the tissues and 
organs of the body. Low oxygen levels are mostly observed in acute inflammatory conditions 
and also within solid tumors [7]. In contrast, hyperoxia might be the result of immoderate 
oxygen delivery to the organism due to unlimited angiogenesis [8].
Transport of oxygen throughout the bodies of animals is achieved via different mechanisms 
that depend on the living environment and the size of each organism. For example, in small 
animals, such as the nematode Caenorhabditis elegans, atmospheric oxygen enters the body via 
diffusion. Insects, such as Drosophila melanogaster, use an elaborate network of tubules, and 
the tracheal system transports oxygen from the outside environment via the spiracular open-
ings to all the cells of the body. Specialized cells of the insect tracheal system, the terminal 
cells, are involved in actual gas exchange and come in close contact with different cells in the 
body that need oxygen. The respiration process and the allocation of oxygen to the trillions of 
cells in the bodies of organisms, such as vertebrates, seem to be more intricate because of their 
large body size. The delivery of oxygen to each part of the human/vertebrate body is achieved 
through the lungs, the diaphragm, the erythrocytes, the heart and the vasculature [3, 9].
1.2. The transcription factor HIF1 is key in oxygen sensing
The hypoxia-inducible factor-1α, HIF-1α, was characterized in 1990 as a transcription factor 
with a key role in oxygen sensing [10]. The discovery of HIF-1α opened new research avenues 
focusing on oxygen sensing and oxygen poverty [10]. Despite the discovery of two additional 
HIFs (the HIF-2α & the HIF-3α) and the variable response of all HIFs to hypoxia, HIF-1α 
remains the molecule with the major role in oxygen sensing [11, 12].
The importance of HIF-1α and oxygen sensing for living organisms is underscored by the evo-
lutionary conservation of this transcription factor in animals. The genomes of different spe-
cies ranging from corals to insects to mammals (i.e., Acropora millepora, Nematostella vectensis, 
Caenorhabditis elegans, Palaemonetes pugio, Drosophila melanogaster, Anopheles gambiae, Apis mellifera, 
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Nasonia vitripennis, Eurosta solidaginis, Tribolium castaneum, Mus musculus) encode homologs of 
the HIF-1α [13]. HIF-1α is present in all metazoans [14] and is characterized as a master regula-
tor of hypoxia-inducible genes in mammals [15]. HIF1 is a heterodimer of two subunits: one 
labile oxygen-sensitive subunit, the HIF-1α and one stable constitutively expressed subunit, the 
HIF-1β [3, 16–18]. The HIF subunits form a subfamily of the basic-Helix-Loop-Helix-Per/ARNT/
Sim (bHLH-PAS) superfamily of transcription factors. The bHLH proteins comprise a super-
family of eukaryotic transcription factors that can dimerize via their HLH domain, and the 
bHLH-PAS proteins are only a small group of this superfamily [18, 19]. The HIF1 heterodimer 
forms a bHLH transcription factor that recognizes and binds the hypoxia-response elements 
(HREs) on DNA. HREs are present in the promoters of HIF target genes, which are involved in 
intracellular homeostatic processes, such as energy metabolism, angiogenesis, erythropoiesis 
and apoptosis [15, 17]. HIF-1α is the main sensor of low oxygen concentrations [20] and is stabi-
lized upon hypoxia and also in response to divalent cations and iron chelators [21].
The human HIF-1α protein is composed of eight regulatory domains: the bHLH DNA binding 
and dimerization domain, the PAS dimerization domain, the amino-terminal and carboxy-termi-
nal nuclear localization signals (NLS-N and NLS-C), the proline-serine-threonine-rich protein sta-
bilization domain (PSTD), the amino-terminal and the carboxy-terminal transactivation domains 
(TAD-N and TAD-C), and the transcriptional inhibitory domain (ID). The HIF-1α peptide consists 
of 826 amino acids, whereas the HIF-1β peptide is smaller with 774 amino acids, because of alterna-
tive splicing in a region that encodes 15 residues [9]. Thus, the two HIF1 subunits have highly con-
served amino acid sequences for the majority of the regulatory domains described above [22, 23]. 
Apart from HIF1 (HIF-1α and HIF-1β), there are also another two HIFs, the HIF-2α and the 
HIF-3α, also known as ARNT2 and ARNT3. Their expression is more restricted in human and 
mouse tissues compared with the HIF-1α and the HIF-1β subunits [24–26].
The expression of functional HIF-1α is controlled at multiple levels, such as transcription, 
nuclear transport, protein stability, and transactivation. Most of the studies have focused on 
the stabilization of HIF-1α protein at in vivo and in vitro changes of oxygen levels [9]. Under 
sufficient oxygen concentrations (normoxia, 21% O
2
), the von Hippel-Lindau (VHL) E3 ubiq-
uitin ligase recognizes and binds to the hydroxylated HIF-1α subunit. VHL binds to HIF-1α 
only when HIF-1α is hydroxylated by the prolyl-4-hydroxylase (PHD). PHD operates as a 
direct sensor of oxygen, because it uses O
2
 as a substrate and attaches –OH groups to par-
ticular proline residues (Pro402 and Pro564 of human HIF-1α) [27]. Binding of VHL recruits 
a ubiquitin ligase complex composed of Elongin C, Elongin B, Cullin 2 (Cul2), and a Ring box 
protein (Rbx1) and attracts a ubiquitin-conjugating enzyme that attaches a polyubiquitin chain 
to HIF-1α to target it for proteasomal degradation [17]. The Pro564 residue of HIF-1α has a 
higher affinity for PHDs compared to the Pro402 residue [28]. However, the hydroxylation of 
the one can affect the hydroxylation of the other [28]. Other factors that play critical roles in 
the regulation of the pathway is the availability of O
2
 and Fe(II), and additionally, whether 
VHL protein can function properly or whether it has a mutation that makes it dysfunctional 
[28]. Furthermore, the control of the process is related to the cell type and the developmental 
phase of the tissue or organ. This regulation can be affected by post-translational events [28].
In hypoxia (1–2% O
2
), the PHD enzyme cannot hydroxylate HIF-1α because oxygen is lacking, 
VHL cannot bind to the HIF-1α subunit, and therefore, HIF-1α is not degraded by the protea-
some [20]. Stabilized HIF-1α is quickly transported to the nucleus to induce the transcription 
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of target genes [20, 29]. In the nucleus, the HIF-1α/HIF-1β heterodimer binds the p300 coacti-
vator [30]. HIF1 and p300 form a complex that binds the double-stranded DNA and promotes 
transcription. HIF-1α has a plethora of target genes, which encode proteins involved in critical 
biological processes, such as erythropoiesis, vascular remodeling, metabolism, cell prolifera-
tion, cell viability and angiogenesis [9, 10] (Table 1).
1.3. HIF-1α controls tumor angiogenesis
Angiogenesis is the process of forming new blood vessels from pre-existing ones, which dif-
ferentiates into a vascular network [53, 54]. Blood vessels supply the body with oxygen, nutri-
ents, and immune surveillance. The extensive growth of veins and their non-physiological 
remodeling result in multiple illnesses, such as cancer and ischemic and inflammatory dis-
eases (e.g., arthritis, atherosclerosis, and diabetes) [54–58]. The veins are used as pathways for 
the migration of cancer cells [54]. Angiogenesis may be adversely affected by infection with 
pathogenic bacteria. Additionally, angiogenesis is a feature of cancer, as tumor cells induce 
the process in order to grow and become metastatic [59].
Previous studies have shown a correlation between tumor growth and angiogenesis and have 
established molecular links between the signaling pathways induced upon infection, gene 
regulation, and cancer [60–63]. According to the angiogenesis dogma, a tumor cannot grow 
more than a few millimeters in diameter, if it does not come in contact with the blood vessels 
by which it receives enough oxygen [54, 61]. Furthermore, due to the irregular shape and 
organization of the tumor vasculature, some cells are more than 100 mm away from the blood 
vessels and they also become hypoxic. The oxygen within the tumor is not static but fluctuates 
spatially and temporally [64]. Angiogenesis is regulated by molecules that act as “activators” 
(pro-angiogenic factors) or “inhibitors” (anti-angiogenic factors) [65]. Several studies have 
shown that the angiogenic activators play an important role in the growth and spread of 
tumors [66]. Key activators of angiogenesis belong to the family of VEGFs, and their receptors 
were found expressed in about half of human cancers investigated so far [66].
Importantly, HIF-1α has been shown to control the expression of proangiogenesis regulators, such 
as VEGF and other growth factors and often activation of their respective pathways feedback to 
enhance HIF-1α activity [9]. For example, the epidermal growth factors (EGFs) act as angiogen-
esis activators. The binding of EGF to the epidermal growth factor receptor (EGFR) activates the 
MAP kinase cascade and also induces the PI3K (phosphatidylinositol 3-kinase)—AKT/PKB (Protein 
Kinase B) pathway. The PI3K enzyme catalyzes the transfer of a phosphate group, which converts PI 
phospholipid (phosphatidylinositol) into PI-3P phospholipid (Phosphatidylinositol 3-phosphate). 
This conversion results in the full activation of the serine/threonine kinase PDK-1 (Phosphoinositide-
dependent kinase), which phosphorylates and activates another serine/threonine kinase, known as 
AKT. PTEN (phosphatase and TENsing homolog), which functions as a kinase with tumor suppres-
sor activity, is a negative regulator of PI3K, which mediates cell proliferation [67]. The protein kinase 
p70S6 is a target of mTOR. Through phosphorylation, it induces the translation of mRNAs, which 
encompass a 5′ end rich in pyrimidines. Such sites are found in the HIF-1α mRNA [68].
1.4. Tumor hypoxia, HIF-1α, and the Warburg effect
The hypoxic regions of a tumor are resistant to chemotherapy, exhibit modified metabolism, 
and often acquire metastatic and invasive properties [69–71]. Chronic cell proliferation, which 
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appears to correlate with tumor incidence, does not only involve cellular dysfunction but also 
energy metabolism adjustments through which the organism acquires enough energy by pro-
ducing ATP, which is used by cancer cells for cell division and growth. In 1924, the Nobelist 
Otto Warburg first described the preference of cancer cells to convert glucose into lactic acid 
Gene name Gene symbol Gene function NCBI 
Gene ID
Refs
Angiopoietin 1
Angiopoietin 2
ANGPT1 ANGPT2 Angiogenesis 284
285
[31]
BCL2 interacting protein 3 BNIP3 Apoptosis 664 [32, 33]
BCL2 interacting protein 3-like BNIP3L/NIX Apoptosis 665 [33]
Endothelin-1 ET1 Angiogenesis 1906 [34]
Enolase 1 ENO1 Energy metabolism 2023 [35]
Erythropoietin EPO Proliferation, survival 2056 [36]
Glyceraldehyde-3-phosphate 
dehydrogenase
GAPDH Energy metabolism 2597 [37]
Glucose transporter-1 GLUT1 Energy metabolism 6513 [38]
Hexokinase 1
Hexokinase 2
HEX1
HEX2
Energy metabolism 3098
3099
[39]
Prolyl 4-hydroxylase subunit alpha 1 P4HA Energy metabolism 5033 [40]
Insulin growth factor 2 IGF2 Growth and survival 3481 [41]
Insulin growth factor binding protein 
1, 2 and 3
IGFBP-1 Growth and survival 3484 [41, 42]
Lactate dehydrogenase A LDHA Energy metabolism 3939 [35]
MAX interactor 1 MXI1 Apoptosis, c-Myc activity 4601 [43, 44]
Nitric oxide synthase 2 NOS2 Angiogenesis 4843 [45]
Pyruvate kinase M PKM Energy metabolism 5315 [35]
Pyruvate dehydrogenase kinase 1 PDK1 Energy metabolism 5163 [46, 47]
Transforming growth factor beta 3 TGF-b3 Invasion, metastasis, growth, 
survival
7043 [48]
Tumor protein p53 p53 Apoptosis 7157 [49]
Twist TWIST Metastasis 7291 [50]
Vascular endothelial growth factor A VEGFA Angiogenesis, growth, 
survival
7422 [51]
Vascular endothelial growth factor 
receptor 1
VEGFR-1/ FLT-1 Angiogenesis, growth, 
survival
2321 [52]
Although several genomic studies have identified a plethora of potential HIF1 targets, here we focus only on direct 
targets of HIF-1α with characterized HREs
Table 1. A list of HIF-1α targets with key functions in a variety of physiological cellular processes, such as angiogenesis, 
survival, and energy metabolism.
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even in the presence of oxygen [72]. By measuring lactic acid production and oxygen consump-
tion in thin sections from healthy and tumorous rat livers, he concluded that normal liver cells 
inhibit the production of lactic acid in the presence of oxygen, whereas cancer cells produced 
lactic acid irrespective of the availability of oxygen [73, 74]. In aerobic conditions, normal cells 
convert glucose to pyruvic acid via glycolysis in the cytoplasm, and then, pyruvic acid is used in 
the mitochondria to produce acetyl Coenzyme A (CoA) and carbon dioxide (CO
2
) during oxida-
tive phosphorylation. In anaerobic conditions, normal cells favor glycolysis, and pyruvic acid is 
used in the cytoplasm to produce lactic acid. Instead, according to Warburg, cancer cells change 
their metabolism, and even in the presence of oxygen, glucose enters glycolysis and produces 
lactic acid. Cancer cells use 10 times more glucose than the amount of the cellular breathing 
process can use, while the amount of lactic acid produced is two times greater than that pro-
duced by healthy cells [73]. This phenomenon is known as the “Warburg effect” or “aerobic gly-
colysis” [70, 75–77]. At first sight, this phenomenon seems paradoxical, since aerobic glycolysis 
produces significantly less energy (4 mol ATP/mol glucose) compared to oxidative phosphory-
lation (36 mol ATP/mol glucose). Nevertheless, cancer cells exhibit an increased expression of 
glucose transporters, such as GLUT1, which correlates with enhanced glucose uptake [78–80]. 
The feeding of cancer cells with glucose is often associated with oncogene activation and loss-
of-function of tumor suppressor genes [78, 79, 81]. The myc oncogene is an important regulator 
of cancer metabolism, since among its many targets, are those of GLUTs as well as genes encod-
ing pyruvate dehydrogenase kinase 1 (PDK1) and lactate dehydrogenase A (LDHA) that pro-
mote the Warburg effect by increasing the flow of glucose through glycolysis, while inhibiting 
the entry of pyruvic acid into the Krebs cycle [82–84]. Furthermore, both the oncoprotein Ras 
and hypoxia can independently increase the levels of the HIF-1α and HIF-2α transcription fac-
tors, which in turn positively regulate glycolysis [85–87]. In addition, loss-of-function mutations 
in tumor suppressor genes, such as vhl [88] and p53 [89, 90], lead to elevated levels of HIF-1α 
and VEGF. Gain-of-function mutations in oncogenes, such as the v-src [91], activation of EGF, 
and insulin growth factor I (IGF-I) receptors, also induce HIF-1α [41, 92].
A series of major discoveries remained as milestones in the field of cancer biology followed 
Warburg’s observations. These include the purification and cloning of the HIF-1 in 1995 [36], 
the effects of HIF-1 in cancer progression in mice [93], the description of VHL [94], the identifi-
cation of the PHD enzymes, and the establishment of the HIF-α subunit prolyl hydroxylation 
[69]. The area of hypoxia remains an attractive subject for intensive research, although over 
a century has passed, since it was first taken into account. With the discovery of HIFs, an 
extremely attractive field of research emerged and novel proteins came into play, such as the 
glucose regulated proteins (GRPs), oxygen regulated proteins (ORPs), PDGF, interleukin-1α 
(IL-1α), endothelin-1, VEGF and erythropoietin (EPO) [95–100]. The characterization of HIF-1 
led to the discovery of upstream activators and downstream signals as potential new thera-
peutic targets. Such targets include the VEGF, fibroblast growth factor (FGF), TGFα, the PI3K/
AKT/mTOR and RAS signaling pathways [101]. In addition, reduced oxygen tensions can 
repress mTOR in the cells similar to the effects of rapamycin. mTOR in hypoxic environments 
acts as an oxygen sensor and leads to reduced protein translation [102].
The PI3K/AKT pathway inhibits programmed cell death and alters cell proliferation [103]. 
Loss of PTEN, which is a negative regulator of the pathway, can lead to increased angiogenesis 
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in the case of prostate cancer. This has been associated with the induction of HIF-1α that 
guides elevated VEGF expression [103, 104]. In colon tumors, transfection of cells with a 
HIF-1α expression vector resulted in elevated VEGF mRNA levels and increased angiogen-
esis [90]. The EGF/PI3K/AKT/TOR pathway promotes VEGF and the transcriptional activity 
of HIF-1α protein in prostate cancer [89]. Chemical inhibitors of PI3K and TOR, the LY294002 
and rapamycin, respectively, inhibited growth factor-induced and mitogen-induced secre-
tion of VEGF. This connected the PI3K/PTEN/AKT/TOR pathway with HIF1 and the process 
of angiogenesis [105]. In the absence of HIF-1α, the development of a tumor is dramatically 
reduced although not completely stalled [106]. Moreover, HIF-1α is overexpressed in differ-
ent cancer types, such as colon, breast and lung carcinomas. HIF-1α is also overexpressed in 
preneoplastic, premalignant adenomas and other intraepithelial neoplasia and also in malig-
nant and metastatic tumors [89]. Therefore, discovery of chemicals that could potentially con-
trol the HIF-1α pathway is of major clinical importance.
1.5. HIF-1α and inflammation
Another important aspect of HIF in tissue maintenance is its role in regulating inflammation 
and innate immunity. HIFs appear to have different functions in different immune cell types. 
For example, HIF-1α mediates bacterial killing via regulation of pro-inflammatory gene expres-
sion in macrophages [107]. On the other hand, in the case of neutrophils, HIF-1α promotes cell 
survival upon hypoxia and promotes extensive angiogenesis which is regulated by β2-integrin 
expression. Furthermore, there is a link between the effect of HIFs in immune cells, inflamma-
tion, and tumorigenesis [107]. It is known that HIF-1α is regulated by the availability of oxy-
gen. Interestingly, not only hypoxia but also bacterial products, such as cytokines and growth 
factors, induce HIF-1α. Inflammatory cytokines, such as tumor necrosis factor a (TNF-α) and 
interleukin-1β (IL-1β), induce HIF-1α transcription. TNF-α induces HIF transcription and the 
Nuclear Factor-kappa B (NF-κB) pathway is needed for stabilization of the protein [108, 109]. 
In the case of IL-1β, the stability of HIF is promoted by the activation of NF-kB activity and 
the inhibition of VHL function [110]. There is an important crosstalk between NF-kB and HIF 
upon inflammation and cancer [111]. NF-kB is activated in inflammatory conditions, includ-
ing cancer, and the activation of the pathway is a characteristic of inflammatory disease [59]. 
Its role in malignant situations is controversial such that it can act both as a tumor promoter 
and as a tumor suppressor [112]. Its activated form is implicated in excessive cell proliferation, 
metastasis, inhibition of apoptosis and angiogenesis [112]. Importantly, cells expressing wild-
type p53 undergo apoptosis in hypoxic conditions, in contrast to the mutant p53 cells that are 
resistant to apoptosis. These results reveal that HIF-1α can promote cell proliferation and thus 
tumorigenesis by inhibiting apoptosis [113]. The chemokine interleukin-8 (IL-8) [114] and the 
VEGF [115] NF-kB target genes promote angiogenesis. Importantly, these are also targets of 
HIF-1α [116, 117], revealing that there is a crosstalk between NF-kB and HIF-1α. This crosstalk 
is bi-directional, because although NF-kB promotes the activation of HIF, HIF restricts the 
transcriptional activity of NF-kB [117]. Inflammation promotes NF-kB activity, which leads 
to tumorigenesis [118]. Not only NF-kB, but also other transcription factors (e.g. STAT3) can 
induce HIF [119]. PHDs antagonize NF-kB in different tumor cells [120–122]. In colorectal 
cancer, NF-kB promotes tumorigenesis. Different signaling pathways drive its oncogenic role. 
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These pathways regulate the production of ROS, the activation of pro-inflammatory cytokines, 
the uncontrolled cell proliferation, migration, metastasis and angiogenesis [123]. The absence 
of NF-kB has a negative effect on tumor progression in mouse models of colorectal cancer 
[124]. ROS affect the hydroxylation of HIF-1α and, thus, modify its activity [125, 126]. Specific 
defects, not necessarily mitochondrial defects, that restrict the consumption of oxygen, result 
in enhanced prolyl-hydroxylation accompanied with reduced HIF levels [125, 127].
The induction of HIF by such inflammatory cytokines indicates that HIF has a crucial role 
in inflammatory responses. Apart from inflammatory cytokines, various signaling path-
ways seem to also have important roles in the stimulation of HIF. Such pathways include 
PHDs [128], NF-κB [129–131], MAPKs [130], and ROS [129]. In addition, ROS are released 
by the mitochondria as a cause of low oxygen tensions, and they can control transcriptional 
and posttranslational events [132]. Another important crosstalk in colorectal cancer is that 
between HIF-1α, β-catenin and APC: when repressed under insufficient oxygen levels, APC 
can lead to activation of the Wnt/β catening signaling and increased proliferation that drives 
tumorigenesis [133]. Interestingly, NF-kB is regulated by Wnt/β-catenin [134].
2. The HIF-1α pathway in Drosophila melanogaster
2.1. The HIF-1α pathway is conserved in Drosophila
The Drosophila melanogaster genome encodes homologs of the core proteins involved in the 
HIF-1α pathway. For example, there are two HIF-1α homologs in fruit flies, one is encoded 
by the gene similar (sima) and its paralogue is known as trachealess (trh) [20, 27, 135]. Sima 
responds to changing oxygen levels, whereas Trh acts as a patterning gene during Drosophila 
development. The HIF-1β homolog in flies is the product of the gene tango (tgo) [136]. Both 
sima and tgo are transcribed during larval stages [136]. Although Tgo is expressed uniformly 
throughout development [137], Sima accumulates in the majority of tissues only in hypoxic 
conditions [138]. Tgo and Sima heterodimerize to control transcription in environments with 
decreased oxygen levels [139, 140].
Sima has a molecular weight of 180 kDa, is larger compared to the mammalian HIF-1α, 
and bears 45% similarity in the PAS domain and 63% in the bHLH domain with its human 
homolog (Figure 1) [141, 142]. The single prolyl-4-hydroxylase (PHD) enzyme homolog in 
Drosophila is encoded by the gene fatiga (fga) and acts as an oxygen sensor. Fga uses O
2
 as a 
substrate and hydroxylates a single Pro residue in Sima (Pro850) [143]. Another factor that 
plays crucial role in the process is the availability of Fe (II) [28]. In normoxia, where O
2
 is 
abundant, Sima is hydroxylated and targeted to the proteasome for degradation via asso-
ciation with the von Hippel-Lindau ubiquitin ligase, which in Drosophila is encoded by the 
dVhl gene [20]. In low oxygen tensions (environmental hypoxia and tumors), the HIF-1α/
Sima transcription factor is not degraded, because it cannot be hydroxylated by Fga due to 
the lack of oxygen. Consequently, HIF-1α/Sima binds to the constitutively expressed HIF-1β/
Tgo forming the HIF1 heterodimer, translocates to the nucleus and binds to hypoxia-response 
elements (HREs) to control transcription of target genes [20, 29] (Table 2).
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2.2. HIF-1α/Sima controls remodeling of the tracheal gas-transporting tubes
In Drosophila melanogaster, an extensive network of interconnected tubes, the tracheal system, 
transfers oxygen throughout the body. The Drosophila trachea is therefore functionally analo-
gous to the mammalian respiratory system [148]. It is responsible for the oxygenation of the 
Figure 1. The human HIF-1α and Drosophila Sima are homologous proteins. (A) The human HIF-1α protein has a length 
of 826 amino acids, whereas its Drosophila homolog Sima is much larger and consists of 1505 amino acids. The shared 
functional domains of the two proteins are indicated with darker color: the bHLH DNA binding and dimerization domain, 
the PAS dimerization domain and the oxygen-dependent degradation domain (ODD). Two Pro residues (Pro402 and Pro564) 
are substrates of the propyl-4-hydroxylase PHD in the human HIF-1α, whereas in Drosophila, the propyl-hydroxylase Fga 
targets a single Sima Pro residue (Pro 850). (B) Amino acid alignment of the human HIF-1α (amino acids 556–575) and the 
Drosophila Sima (amino acids 841–861) highlighting in red the hydroxylation targets Pro564 and Pro850, respectively. Dark gray 
and light gray boxes indicate identical residues and conservative amino acid substitutions in the two proteins, respectively.
Gene name Gene 
symbol
Human 
homolog
Gene function NCBI Gene 
ID
Refs
branchless bnl FGF10 Tracheal development, cell 
migration
42356 [144]
breathless btl FGFR Tracheal development, cell 
migration
39564 [144]
Ecdysone-inducible gene 
L3
ImpL3 LDHA Energy metabolism 45880 [145]
fatiga B fgaB HPH3 Energy metabolism 40633 [146]
heat shock factor hsf HSF1 Heat response, defense response 37068 [147]
Table 2. A list of Sima targets identified by genetics and direct binding assays.
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flight muscles, the brain and all internal organs, such as the intestine. The tracheal system of 
the fly is a good model for studying tracheal cell migration and the mechanisms that direct the 
movement of cells in different directions [149]. Systematic studies of the molecular markers 
labeling the trachea, mutational studies on specific genes and cellular imaging have identified 
the basic steps in the development of the tracheal system. Embryonic tracheal morphogenesis is 
initiated at stage 10 of embryogenesis and proceeds through four sequential steps: the formation 
of the tracheal placode and the sprouting of the primary, secondary and tertiary branches [148]. 
Tracheal cell specification and primary and secondary branch formation are genetically con-
trolled stereotypical processes, whereas terminal branching is environmentally controlled and 
adjusted according to the needs of the tissue for oxygen [148]. After embryogenesis and during 
larval life, the fly trachea grows in size to accommodate the increased oxygen needs of the larva. 
At the same time, specialized airway progenitors, the tracheoblasts, get activated to prolifer-
ate and differentiate to remodel the pupal and adult tracheal system during metamorphosis 
[150–154]. The FGF/FGFR pathway controls all aspects of tracheal morphogenesis. In flies, the 
FGF homolog encoded by the gene branchless (bnl) and the FGFR homolog encoded by the gene 
breathless (btl) are repeatedly utilized for tracheal development and remodeling. Bnl/FGF acts as 
a chemoattractant that can direct tracheal sprouting in cells expressing the Btl/FGFR [155–157].
Remarkably, Drosophila adults and larvae present a different mode/pattern of response during 
hypoxia. In adult Drosophila, this response includes the opening of the spiracles, the aeration of 
the body and the transposition of the fluids from the tracheoles [158, 159]. It has been shown that 
the majority of insects can survive in complete anoxia for quite a long period in contrast to mam-
mals. The survival of adult Drosophila melanogaster under anoxia without any tissue damage and 
reaches a period of about 4 hours [160]. This time interval depends on the developmental stage 
of the animal. For example, larvae illustrate escape mobility for 20 minutes in these conditions 
[161], whereas adult Drosophila remains stationary within a period of only 60 seconds, and this 
is because of the effacement of the electrical responses of the insect muscles [160]. The reten-
tion of flies in anoxia for 12 hours leads to death [162]. Furthermore, the survival of the flies in 
anoxia depends on the suppression of ATP synthesis, with simultaneous reduction of the harm-
ful reverberations of low energy availability [161]. Interestingly, although flies challenged for 6 
hours in 0.5% O
2
 stop responding and remain motionless, following their reoxygenation, they 
behave physiologically without any defects [163]. Moreover, the behavior of Drosophila under 
low oxygen conditions depends on the degree of hypoxia and whether it is constant or intermit-
tent [164]. Different gene families have been found regulated in different types of hypoxia. For 
example, in flies that experienced intermittent hypoxia, a smaller proportion of altered genes has 
been observed, in comparison with the flies that experienced constant hypoxia. The same flies 
revealed decreased metabolic rates and loss of spiracular control [165, 166]. In Drosophila, the 
adaptation to hypoxia involves mechanisms that increase oxygen delivery, such as the expan-
sion of the spiracular openings, as noted above, that are able to propel oxygen to the whole 
organism [158]. The expression of HIF1 increases the diameter of tracheal tubules and induces 
the expansion of cells that directly contact target tissues, the tracheoles [167].
Interestingly, the embryonic and larval fly trachea encompasses specialized cells, which extend 
cytoplasmic processes to carry oxygen to the tissue. These cells, known as tracheal terminal 
cells, are very similar to the tip cells of the mammalian blood vessels; they are plastics and they 
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respond to hypoxia by extending cytoplasmic tubular processes, the terminal branches, toward 
the hypoxic tissue [148]. The sprouting and growth of the terminal branches are carefully 
adjusted according to the needs of tissue in oxygen, just as in the case of sprouting angiogenesis 
in mammals. Hypoxia induces terminal branching, whereas hyperoxia (increased oxygen sup-
ply) suppresses the formation of terminal branches [148, 168]. Hypoxia induces the expression 
of bnl/FGF, which acts as a chemoattractant that can direct the newly formed branches of every 
cell that expresses the FGFR/Btl [148]. The formation of new branches depends on the HIF-1α 
homolog Sima and the HIF-propyl hydroxylase Fga, which acts as an oxygen sensor [144]. In 
hypoxia, HIF-1α/Sima accumulation in tracheal cells induces the expression of btl/FGFR and 
thus causes further sprouting of new branches, whereas in nontracheal cells, Sima contributes 
to the induction of bnl/FGF [144]. Therefore, the hypoxia-induced trachea-specific btl/FGFR 
expression, probably, enhances their sensitivity in the presence of high levels of Bnl [144]. In 
nontracheal target tissues, such as the larval muscle, the Archipelago (Ago) F-box/WD-repeat 
protein substrate specificity factor for a Skp/Cullin/F-box (SCF)-type polyubiquitin ligase has 
been shown to antagonize HIF-1α/Sima-dependent bnl/FGF expression. Ago physically associ-
ates with HIF-1α/Sima, reduces its levels, and inhibits the hypoxic response [29, 169]. Thus, ter-
minal cell remodeling in Drosophila is controlled by the evolutionarily conserved HIF-1α/Sima 
pathway, similar to tip cell remodeling of mammalian blood vessels [136, 170].
2.3. HIF-1α/Sima and growth control in Drosophila
Insects have a mechanism of body size plasticity. Oxygen sensing has a major role in this mech-
anism. Hypoxia causes a reduction of body size in the fruit fly Drosophila and the moth Manduca 
[171]. The primary regulators of this phenotype are the HIF1 and nitric oxide synthase (NOS) 
signaling pathways, which are activated in hypoxia. In normoxia, NO inhibits HIF-1α at the 
level of protein hydroxylation that targets it to the proteasome for degradation [171].
Over the last decade, many scientists tried to address the role of HIF in cell growth and cell size 
control. Overexpression of HIF-1α/sima in the fat body resulted in smaller cells compared to 
the control wild type cells, indicating that Sima operates as a cell-autonomous negative growth 
regulator [140]. In addition, fga mutant pupae revealed reduced rate of growth and smaller size 
compared to wild type [140]. Cells with fga loss-of-function in the larval fat body were found 
smaller compared to the wild type cells in the same tissue [172]. In contrast, overexpression of 
the same gene in the wing imaginal discs led to the growth of the cells [140]. HIF uses at least 
two mechanisms to control the cellular growth in Drosophila. It can block protein synthesis, by 
targeting the insulin-like peptide (ILP)-TOR-S6 K pathway, and as a consequence, there is a 
reduction of cellular growth of the whole animal. This has been so far seen in the fat tissue, the 
eye and the gut of Drosophila [173]. In addition, Drosophila mutants overexpressing or lacking the 
gene fga revealed that HIF controls the function of the cyclin-dependent protein kinase 4 (Cdk4), 
which is responsible for the activation of cellular growth [172]. Moreover, HIF is also implicated 
in the expression of scylla and charybdis genes that downregulate the S6 K-dependent activation 
of protein synthesis, and this results in the reduction of cellular and body growth [173].
It is firmly established that insulin growth factors and components of the insulin pathway 
upregulate the HIF-1α protein, thus promoting the expression of hypoxia-sensitive genes 
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[174]. The PI3K/Akt/TOR signaling pathway is directed by insulin to induce the transcription 
of HIF-1α/Sima both in S2 cell lines and in Drosophila embryos [175]. Thus, the transcriptional 
activation of HIF-1α/Sima is guided by the insulin receptor (InR)-regulated PI3K-AKT and 
TOR signaling pathways [175]. RNAi silencing experiments showed that the mRNA levels 
of HIF-1α/sima, upon induction with insulin, depended on those two pathways. Experiments 
in fly embryos, where components of these pathways were overactivated, also revealed the 
upregulation of sima mRNA levels [175]. As noted above, the overexpression of sima in dif-
ferent tissues of the fly resulted in the reduction of cell size in these specific tissues [140]. But 
this is not consistent with our knowledge about the role of PI3K-AKT and TOR pathways in 
correlation with Sima and cell growth. Particularly, it is known that the activation of these 
pathways induces growth in different levels, and in parallel with this, it also induces the tran-
scription of genes that are targeted by Sima. However, Sima is a negative regulator of growth. 
It seems like there is a negative feedback loop, in which the two pathways upregulate growth 
and Sima simultaneously, and then, Sima downregulates the two pathways, and this conse-
quently results in growth limitation [176]. Interestingly, Sima induces scylla in hypoxic condi-
tions, which in turn feeds back on the TSC1 complex to inhibit the TOR pathway and growth. 
Thus, scylla seems to be part of the negative feedback loop that coordinates InR-mediated 
growth with HIF-1α/Sima induction during hypoxia [173].
2.4. Other functions of HIF-1α/Sima in Drosophila
2.4.1. Epithelial cell migration
A 2010 study dealt with the role of Sima in the rate of cell migration and invasion of the ovarian 
border cells in Drosophila. In more detail, the researchers studied the role of hypoxic response 
and HIF-1α/Sima during invasion and metastasis. It was shown that the HIF pathway con-
trolled the rate or invasion in the ovary cells in a dose-dependent manner [177]. It seems that 
precise amounts of Sima are needed for the actual border cell migration. It became also clear 
that Sima was important for the specificity of the leading cells to reside at the edge of their 
cluster. Changes in the expression of the DE-cadherin adhesion protein also implicated Sima 
[177]. Notably, Sima regulates the activity of the transcription factor slow border cells (Slbo) 
that is necessary in border cells for their migration [177, 178]. Changes in HIF expression and 
activity in just a single migrating border cell of the cluster can lead to metastasis in this model 
[177]. Overexpression of vhl led to delay, blockage and acceleration of the border cell migra-
tion. Overexpression of fga exhibited only acceleration of border cell migration. Moreover, 
sima and tgo mutants demonstrate a delayed or accelerative behavior for border cell migration. 
Therefore, HIF1 activity is required for the conservation of invasive dynamics of the cells that 
migrate [177].
2.4.2. Blood cell differentiation
A recent study dealing with the role of HIF-1α in Drosophila blood cells focused on the interac-
tions between Notch and HIF-1α. A specific lineage of Drosophila blood cells, the crystal cells, 
expressed elevated levels of Sima, even in normoxia [179]. Overexpression of sima results in 
expansion of the population of crystal cells, phenocopying the effect of Notch overexpression. 
Gene Expression and Regulation in Mammalian Cells - Transcription Toward the Establishment of Novel Therapeutics220
Thus, both molecules act in the same pathway in the lymph gland. Elevated activation of 
Notch in crystal cells is further increased in a sima overexpression background [179] and the 
full-length Notch (Nfl) receptor can be activated by sima in a ligand-independent manner. This 
happens also in hemocytes that also express sima. The Nfl is sufficient to increase the number 
of crystal cells. Even though Tgo acts together with Sima, tgo mutants did not reduce the 
numbers of crystal cells, but they led to an increase in their number [179]. In Drosophila, nitric 
oxide (NO) inhibits PHD and thus promotes the stabilization of Sima, whereas upon hypoxic 
conditions, it leads to reduced induction of HIF [180–182]. Nitric oxide synthase 1 (NOS1) is 
highly expressed in mature crystal cells, and its knockdown in the lymph gland by RNA inter-
ference (RNAi) leads to reduced numbers of crystal cells. NOS1RNAi clones revealed low levels 
of the Sima protein and were unable to form crystal cells. In conclusion, Sima is necessary for 
differentiation of crystal cells in the fly lymph gland [179].
2.5. Upstream regulators of HIF-1α/Sima in hypoxia
A genome-wide RNAi screen was deployed in Drosophila cells in culture to reveal genes 
required for the activation of HIF-1α/Sima [183]. More specifically, 30 genes appeared for 
the first time as candidate regulators of HIF in low oxygen concentration conditions, and 
these specific genes mediated the alteration to oxygen starvation. These genes included tran-
scription elongation factors, translation regulators and components of chromatin remodeling 
complexes [183]. The ago1 (argonaute 1) gene, which has a critical role in microRNA silenc-
ing processes, was also identified in this screen as a regulator of Sima in hypoxia. Given the 
involvement of Ago1 in Sima regulation, the authors went further to show that the microRNA 
pathway has a central role in HIF-dependent transcription, and also that Sima mRNA stabili-
zation has a critical role in the Drosophila response to hypoxia [183].
Further work on Sima regulators has uncovered several modifiers of Sima function in hypoxia 
in Drosophila, such as the microRNA miR-190, the TIP60 chromatin remodeling complex and 
the RNA-binding protein Musashi [184–186] (Figure 2). miR-190 acts as a positive regulator 
of the hypoxic response by targeting directly the propyl-4-hydroxylase Fga, which is the prin-
cipal negative regulator of Sima. Specifically, miR-190 is upregulated in hypoxia, reduces Fga 
activity and, thus, allows the Sima-mediated response to hypoxia [184]. In addition, the TIP60 
complex is required for HIF1-dependent gene expression in fly cells and embryos, as well 
as colorectal cancer cells. TIP60 is recruited by HIF1 to chromatin during hypoxia and func-
tions as a coactivator of HIF1 action by recruiting RNA-Polymerase II onto chromatin [186]. 
Finally, Musashi (Msi, dMsi in Drosophila) represses sima mRNA translation by binding an 
Msi-binding element within the 3′ UTR of the sima transcript. dMsi protein levels are reduced 
in hypoxia, allowing Sima transcription. Thus, dMsi mediates translational repression of the 
Drosophila HIF-1α, Sima. Moreover, association of murine Msi with the HIF-1α transcript sug-
gests that a similar mechanism might be conserved in mammals [185].
2.6. HIF-1α/Sima in Drosophila tumorigenesis
The connection between metabolism deregulation and tumorigenesis is already established 
[187] and various signaling pathways with crucial roles in cancer progression regulate the 
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expression of metabolic genes encoding key glycolytic enzymes [78, 79, 188]. In addition, the 
transcription factor HIF-1α controls expression of a number of genes involved in different 
hallmarks of cancer including modifiers of cellular metabolism that facilitate neoplasia [189]. 
A recent study in Drosophila investigated the mechanisms impinging on metabolism deregu-
lation under sufficient oxygen levels and the role of HIF-1α in this process [145] (Figure 3). 
The authors induced a glycolytic tumor in the fly wing imaginal disk by expressing an acti-
vated form of the PDGF/VEGF-receptor (Pvr) oncogene, and they observed whether vari-
ous oncogenic signaling pathways can interact with HIF-1α/sima and successively upregulate 
key metabolic enzymes [145]. Pvr was found to induce strong lactate dehydrogenase (LDH) 
enzymatic activity, which is a hallmark of aerobic glycolysis and the Warburg effect. Pvract 
expression along the anterior-posterior boundary of the wing disk caused extensive growth 
and dysplasia, and the cells within the mass of this tumor expressed LDH. Thus, the activa-
tion of Pvr resulted in ldh upregulation, which led to increased LDH enzymatic activity in the 
tumor. Since Pvr is an RTK, the authors asked if other activated RTKs that lead to overprolif-
eration may also cause increased LDH activity. Interestingly, they found that, unlike Pvract, 
InRact and Egfract did not induce any LDH expression [145]. Sima, one of the key inducers of 
LDH in tumors [189], was assessed next, and it was found that Sima protein was stabilized in 
a Pvract background and its overexpression led to LDH-induced activity [145]. When silenc-
ing sima in the same background, LDH expression was suppressed. Thus, Sima is necessary 
for the activation of LDH. Rasact, an effector of all RTKs, was also sufficient to increase LDH 
activity. Blocking PI3K signaling by targeting different components of the signaling cascade 
(PI3K, Akt and TOR) led to the suppression of the LDH-GFP reporter proving that the PI3K/
Akt/TOR axis is necessary for LDH regulation. Co-expression of a gain-of-function allele of 
human Raf (hRafact) and activated PI3K (PI3Kact) led to extensive LDH activation, whereas 
Figure 2. The HIF-1α signaling pathway is conserved between Drosophila and mammals. In normoxia, the PHD (Fga in 
flies) catalyzes the hydroxylation of HIF-1α (Sima in flies). Binding of the hydroxylated HIF-1α by the tumor suppressor 
protein VHL (dVHL in flies) leads to HIF-1α/Sima polyubiquitination and degradation by the proteasome. In hypoxia, 
HIF-1α/Sima is stabilized and dimerizes with HIF-1β (Tgo in flies) forming the HIF1 heterodimer. HIF1 is translocated 
to the nucleus, binds HREs, and induces the transcription of hypoxia-responsive genes.
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PI3K/ERK activation led to extensive Sima expression. In the absence of Sima, the PI3K/ERK 
LDH-GFP expression was reduced. Thus, PI3K and ERK together are necessary and sufficient 
to induce LDH expression; each signal alone is necessary, but not sufficient, to induce LDH 
expression. Another known factor that stabilizes HIF-1α is the secretion of ROS even in the 
presence of sufficient oxygen levels [190]. Peroxidasin (Pxn), a general antioxidant, reduced 
ROS activity, and when it was expressed together with Pvract led to the deactivation of the JNK 
pathway (previously active in a Pvract background), the suppression of Sima protein accumu-
lation and the reduction of LDH activity. Thus, ROS have a crucial role in metabolism regula-
tion [145]. Moreover, ROS are the central players in the metabolic profile of the cell [191]. They 
can activate the JNK signaling pathway and use the same mechanisms as hypoxia to stabilize 
HIF-1α [190, 192]. ROS use a positive feedback loop to strengthen the upstream members 
of the glycolytic pathway, which is the key point in the metabolic reprogramming of cancer 
tissues, not only in the absence of sufficient oxygen tensions. Even though hypoxia stabilizes 
HIF-1α, in the metabolic reprogramming of the cell, hypoxia, unlike HIF-1α, does not play an 
important role [145]. Interestingly in this study, although Pvr activation was linked to many 
tumor phenotypes, such as cell shape changes, overproliferation, aerobic glycolysis and local 
migration, it did not possess any metastatic capability, which correlated with no loss of the 
cell epithelial polarity that leads to invasive and metastatic abilities [193].
Figure 3. Sima activity is regulated at different levels. In hypoxia, the propyl-4-hydroxylase Fga regulates Sima 
protein levels post-translationally by promoting its degradation by the proteasome, whereas the RNA-binding protein 
dMsi represses sima mRNA translation. miR-190 is upregulated in hypoxia and inhibits Fga directly, which, in turn, 
downregulates Sima. Binding of the Sima/Tgo HIF1 heterodimer on the HREs of promoters of hypoxia-responsive genes 
is necessary for recruitment of the TIP60 chromatin remodeling complex, which, in turn, promotes recruitment of RNA-
PolII and efficient transcription.
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An independent study also assessed Sima expression, as well as induction of tracheogenesis in 
Drosophila epithelial tumors [194] (Figure 3). In Drosophila, genes involved in the maintenance 
of apicobasal polarity, such as lethal giant larvae (lgl), discs large (dlg) and scribble (scrib), have 
been shown to also regulate growth and act as tumor suppressors [195]. Tumors caused by 
expression of an lgl knockdown (lglKD) in a Minute background in the wing disc of Drosophila 
melanogaster revealed a conserved response to hypoxic stress and also migratory and tracheo-
genic behaviors [194]. In addition, tumors generated when a loss-of-function mutation of 
the gene l(2)gl4 was combined with the oncogenic form of Ras, RasV12, expressed bnl/FGF and 
formed new trachea-like branched structures. Strikingly, cells within the tumor expressed 
the gene trh, a paralogue of sima, which is necessary for btl/FGFR expression and serves as a 
classic tracheal cell marker in Drosophila [135, 196]. These tumor cells induced extra branching 
of the trachea that was associated with the tumor (similar to sprouting angiogenesis), they 
synthesized de novo new patterns of trachea-like branches (similar to vascular mimicry), and 
they migrated toward and incorporated into neighboring pre-existing tracheal tubes (similar 
to vascular cooption). Importantly, expression of trh in the tumor cells transformed some of 
them to tracheal cells, giving them a different cellular identity and contributing to tumor het-
erogeneity [194]. Sima exhibited nuclear localization in some of the tumor cells, and this led 
to activation of the bnl/FGF promoter. Furthermore, the Polycomb group (PcG) of proteins, 
which are known epigenetic regulators leading to transcriptional repression in Drosophila, 
was downregulated in the undifferentiated cancer cells, whereas when these cells turned into 
tracheal cells, they started expressing PcG. This is in agreement with the known function of 
PcG, which is lowly expressed in stem cells/undifferentiated cells and is upregulated in dif-
ferentiated cells to lock a particular cell fate [197]. During this epithelial-to-tracheal switch, the 
JAK/STAT signaling pathway activity was also observed. A correlation between PcG repres-
sion and JNK activity was found, whereas the inhibition of JNK led to the opposite result [194]. 
This publication characterized tracheogenesis of Drosophila melanogaster as a novel hallmark 
of cancer reminiscent of tumor angiogenesis, establishing this model organism as a powerful 
and promising model for the study of the molecular alterations in the hypoxic microenviron-
ment of the tumor.
3. Conclusions and future perspectives
This book chapter discusses our current knowledge on HIFs and their major roles in develop-
ment, physiology and disease pathology, using examples of studies in the model organism 
Drosophila melanogaster. The mammalian HIF-1α transcription factor regulates a plethora of 
genes that promote various aspects of cancer, such as metabolism, invasive motility, growth, 
angiogenesis and drug resistance (Table 1) [189, 198, 199].
The HIF-1α transcription factor has been extensively studied in mammals and in a variety of model 
organisms due to its highly conserved sequence and function (Figure 1). The extensive literature on 
the Drosophila HIF1 pathway suggests that the fruit fly is a potentially good model to study the basic 
mechanisms of HIF-1α/Sima regulation (Figure 2) and identify novel members of the pathway in 
normoxia and hypoxia (see above). Indeed, a series of studies in Drosophila have identified novel 
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regulators of HIF-1α, which are conserved in mammals and potentially could function in a similar 
way on mammalian HIF1 [169, 184, 185, 200] (Figure 3). Strikingly, recent studies in Drosophila 
[145, 194] underscore the key role of HIF-1α/Sima in tumorigenesis and tumor angiogenesis and 
suggest that the fruit fly can serve as a great model for studies of the Warburg effect and patho-
logical angiogenesis (Figure 4). Impressively, expression of a single oncogene, the activated Pvr, in 
Drosophila can cause glycolytic epithelial tumors that turn on HIF-1α/Sima expression and the gly-
colysis pathway at the expense of oxidative phosphorylation [145]. Moreover, epithelial neoplasias 
caused by inactivation of tumor suppressor genes, such as lgl, in combination with oncogenic Ras 
are heterogeneous, and some cells in the tumor induce expression of HIF-1α/Sima, trh, and bnl/FGF, 
and a subset of them differentiate into tracheal cells. Therefore, these tumors can promote processes 
reminiscent of sprouting angiogenesis, vascular cooption and vascular mimicry and indicate that, 
although Drosophila does not possess typical blood vessels, its tracheal system may function similar 
to mammalian blood vessels in pathological situations.
The contribution of HIF-1α/Sima in epithelial tumorigenesis and tracheogenesis in Drosophila is 
intriguing especially in the light of various studies that show a close proximity of tracheal cells 
with healthy and tumorous epithelia. For example, metastatic tumor cells have been shown to 
adhere and move alongside the tracheal network [193, 201] and expansion of the trachea has 
been observed in a PI3K/Ras glioma model in larval and adult brains [202]. In addition, the adult 
Figure 4. Drosophila epithelial tumors induce Sima, the Warburg effect and angiogenesis-like phenotypes. Pvract triggers 
the activation of the PI3K/Akt and Raf/ERK signaling pathways in a Ras-dependent manner controlling Sima activity. 
Pvract requires JNK activation, which blocks OXPHOS through the production of ROS. ROS produced by the metabolic 
reprogramming of the tumor responds to the upstream components in order to maintain the Warburg effect. Thus, there 
is a positive feedback loop that sustains the Warburg effect over time through the activation of LDH, which is induced 
by Sima. Overall, this mechanism is HIF-dependent but hypoxia-independent. In lgl-Ras epithelial neoplasias, tumor 
hypoxia leads to stabilization of Sima and bnl/FGF transcription, as well as STAT92E-dependent trh expression, which 
strengthens activation of the btl/FGFR promoter. All these events promote tumor tracheogenesis via three different 
strategies reminiscent of tumor angiogenesis: sprouting tracheogenesis, tracheal cooption and tracheal mimicry.
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fly intestine is oxygenated by an extensive network of visceral trachea that has been shown to 
contribute growth and regeneration signals to the intestinal stem cells [203–205]. Recently, it 
has been shown that mutations of the Sox21α transcription factor cause heterogeneous intesti-
nal neoplasias, inside which some tumor cells express btl/FGFR, suggesting maybe a phenom-
enon of tracheal mimicry or cooption [206]. Since many oncogenes and tumor suppressors as 
well as combinations of mutations with cellular stress caused by pathogens or chemicals can 
lead to intestinal dysplasia in flies [207, 208], it remains to be seen if and how the HIF-1α/Sima-
promoted metabolic changes and tracheogenesis interact with the tumorous environment.
Undoubtedly, Drosophila melanogaster has still a lot to contribute toward our understanding of 
HIF-1α regulation in physiology, hypoxia, tumorigenesis, and angiogenesis. Understanding 
the function of the HIF pathway in genetically tractable invertebrates will allow the discovery 
of novel-conserved pathway components that may be used as therapeutic targets in humans.
Abbreviation
ago1  argonaute 1
Ago  Archipelago
ARNT2  aryl hydrocarbon receptor nuclear translocator 2
ARNT3  aryl hydrocarbon receptor nuclear translocator 3
ATP  adenosine tri-phosphate
bHLH-PAS basic-Helix-Loop-Helix-Per/ARNT/Sim
bnl  branchless
btl  breathless
Cdk4  cyclin-dependent protein kinase 4
CoA  acetyl coenzyme A
CO
2
  carbon di oxide
Cul2  cullin 2
dlg  discs large
dMsi  Drosophila Mushashi
EGFR  epidermal growth factor receptor
EGFs  epidermal growth factors
EPO  erythropoietin
fga  fatiga
FGF  fibroblast growth factor
GLUTs  glucose transporters
GLUT1  glucose transporter 1
GRPs  glucose regulated proteins
HIFs  hypoxia-inducible factors
HIF1  hypoxia-inducible factor 1
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HIF-1α  hypoxia-inducible factor-1α
HIF-1β  hypoxia-inducible factor-1β
HIF-2α  hypoxia-inducible factor-2α
HIF-3α  hypoxia-inducible factor-3α
hRafact  human Raf gain-of-function
HREs  hypoxia-response elements
ID  inhibitory domain
IGF-I  insulin growth factor I
ILP  insulin-like peptide
IL-1α  interleukin-1α
IL-1β  interleukin-1β
IL-8  interleukin-8
InR  insulin receptor
LDH  lactate dehydrogenase
LDHA  lactate dehydrogenase A
lgl  lethal giant larvae
lglKD  lgl knockdown
miR  microRNA
Msi  Musashi
NF-κB  nuclear factor-kappa B
Nfl  Notch full-length
NLS-C  carboxy-terminal Nuclear Localization Signals
NLS-N  amino-terminal Nuclear Localization Signals
NO  nitric oxide
NOS  nitric oxide synthase
NOS1  nitric oxide synthase1
ORPs  oxygen regulated Proteins
OXPHOS oxidative phosphorylation
O
2
  oxygen
PcG  polycomb group
PDGF-β  platelet-derived growth factor beta
PDK1  pyruvate dehydrogenase kinase 1
PDK-1  phosphoinositide-dependent kinase 1
PHD  prolyl-4-hydroxylase
PI  phosphatidylinositol
PI3K  phosphatidylinositol 3-kinase
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PI3Kact  PI3K activated
PI-3P  phosphatidylinositol 3-phosphate
PKB  protein Kinase B
Pro  proline
PSTD  Proline-Serine–Threonine-rich protein stabilization Domain
PTEN  phosphatase and TENsing homolog
Pvr  PDGF/VEGF-receptor
Pxn  peroxidasin
Rbx1  ring box protein 1
RNAi  RNA interference
ROSs  reactive oxygen species
scrib  scribble
sima  similar
Slbo  slow border cells
TAD-C  carboxy-terminal transactivation domains
TAD-N  amino-terminal transactivation domains
TGF-α  transforming growth factor alpha
tgo  tango
TNF-α  tumor necrosis factor α
trh  trachealess
VEGF  vascular endothelial growth factor
VHL  von Hippel-Lindau
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